Oxford Biodynamics (LON:OBD) Announces Earnings Results

Oxford Biodynamics (LON:OBD) issued its quarterly earnings results on Tuesday. The biotechnology company reported GBX (3) (($0.04)) earnings per share (EPS) for the quarter, Digital Look Earnings reports.

Shares of LON:OBD traded down GBX 2 ($0.03) during midday trading on Thursday, reaching GBX 101.50 ($1.34). The company’s stock had a trading volume of 13,489 shares, compared to its average volume of 67,675. The firm has a market capitalization of $93.95 million and a PE ratio of -44.13. Oxford Biodynamics has a twelve month low of GBX 75.11 ($0.99) and a twelve month high of GBX 214 ($2.82). The stock has a fifty day moving average of GBX 117.26 and a 200 day moving average of GBX 115.01.

Separately, Shore Capital restated a “house stock” rating on shares of Oxford Biodynamics in a research note on Friday, October 25th.

In other Oxford Biodynamics news, insider Stephen Charles Diggle acquired 18,309 shares of the business’s stock in a transaction dated Tuesday, December 10th. The shares were purchased at an average price of GBX 104 ($1.37) per share, for a total transaction of £19,041.36 ($25,047.83).

Oxford Biodynamics Company Profile

Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures.

Read More: How to Track your Portfolio in Google Finance

Receive News & Ratings for Oxford Biodynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biodynamics and related companies with MarketBeat.com's FREE daily email newsletter.